Adenosine Receptor A3 (ADORA3) Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Adenosine Receptor A3 (ADORA3) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Adenosine Receptor A3 (ADORA3), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Adenosine Receptor A3 (ADORA3) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Adenosine Receptor A3 (ADORA3) Overview
  3. Therapeutics Development
  4. Pipeline Products for Adenosine Receptor A3 (ADORA3) - Overview
  5. Pipeline Products for Adenosine Receptor A3 (ADORA3) - Comparative Analysis
  6. Adenosine Receptor A3 (ADORA3) - Therapeutics under Development by Companies
  7. Adenosine Receptor A3 (ADORA3) - Therapeutics under Investigation by Universities/Institutes
  8. Adenosine Receptor A3 (ADORA3) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Adenosine Receptor A3 (ADORA3) - Products under Development by Companies
  13. Adenosine Receptor A3 (ADORA3) - Products under Investigation by Universities/Institutes
  14. Adenosine Receptor A3 (ADORA3) - Companies Involved in Therapeutics Development
  • Can-Fite BioPharma Ltd.
  • Huons Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/nwftjv/adenosine

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Endocrine and Metabolic Disorder Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Endocrine and Metabolic Disorder Drugs